Compare AbCellera Biologics Inc (ABCL) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Vanguard Short Term Corporate Bond ETF trades at $78.52. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| ABCL | VCSH | |
|---|---|---|
Market Cap | $2.99B | — |
Sector | Health | Fixed Income |
52-Week High | $9.76 | $80.20 |
52-Week Low | $2.78 | $78.41 |
Enterprise Value | $2.58B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
